imm-1-104
immuneering
['imm-1-104', 'immuneering']
join us for a virtual investor event tuesday, april 18 at 9am et to discuss initial phase 1 pharmacokinetic, pharmacodynamic modeling &amp; safety data from our universal-ras program, imm-1-104, being presented at #aacr23. register at 